With Q1 behind us, let’s have a look at Myriad Genetics (NASDAQ:MYGN) and its peers. Over the next few years, therapeutic companies, which develop a wide variety of treatments for diseases and ...

When a baby born in Philadelphia was announced as the first person to get a gene therapy designed just for him, many people hailed the achievement as a starting point to treat virtually any ...

An international research team from the University of Tübingen, the Senckenberg Center for Human Evolution and Palaeoenvironment and the Universidad Nacional de Colombia have now found genetic ...

KJ Muldoon was diagnosed with a rare, deadly genetic disease after he was born. KJ Muldoon, a 10-month-old baby who sparked nationwide headlines after receiving a first-of-its kind gene-editing ...

The sperm of a man carrying a rare genetic mutation linked to cancer was used to conceive scores of children across Europe, prompting calls for greater regulation and a limit on the number of ...

While rare genetic diseases are uncommon, as their name suggests, there are more than 7,000 types of disease caused by mutations in more than 5,000 known genes, affecting approximately 300 million ...

The FDA has slapped a clinical hold on Rocket Pharmaceuticals’ pivotal gene therapy trial in response to a death. Rocket, which was aiming to report data in mid-2026, dropped its targeted trial ...

Police are crediting the use of investigative genetic genealogy in helping to identify a man whose lifeless body was found nearly 30 years ago. Toronto Police provided an update on the cold case ...

You can reach Jason on Signal at JasonMast.05. Rocket Pharmaceuticals said Tuesday that a patient had died in a trial studying its experimental gene therapy for a rare heart condition called Danon ...

New research has uncovered how specific genetic variations determine whether individuals are more likely to develop autism-like traits or psychosis, offering new insights into the genetic roots of ...